Blinding was judged more difficult to achieve and maintain in nonpharmacologic than pharmacologic trials
- 30 June 2004
- journal article
- Published by Elsevier
- Vol. 57 (6) , 543-550
- https://doi.org/10.1016/j.jclinepi.2003.12.010
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Turning a blind eye:Why we don't test for blindness at the end of our trialsBMJ, 2004
- A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the KneeNew England Journal of Medicine, 2002
- Blinding in randomised trials: hiding who got whatThe Lancet, 2002
- The double-blind, randomized, placebo-controlled trialJournal of Clinical Epidemiology, 2001
- Statistics Notes: Blinding in clinical trials and other studiesBMJ, 2000
- Do medical devices have enhanced placebo effects?Journal of Clinical Epidemiology, 2000
- Randomized controlled trials in surgery: Issues and problemsSurgery, 1996
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Do readers and peer reviewers agree on manuscript quality?Published by American Medical Association (AMA) ,1994
- Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trialsBlood Pressure, 1992